TeamTalk: Meet the MiRXES Wonder Women
Across the many functional teams in MiRXES, from R&D to manufacturing and commercial, our women in science wear many different hats—to great success.
Across the many functional teams in MiRXES, from R&D to manufacturing and commercial, our women in science wear many different hats—to great success.
As the world’s first molecular blood test for detecting gastric cancer, GASTROClear could play a pivotal role in stopping the deadly disease in its earliest stages.
Press Release MiRXES Welcomes Genomics Expert to Scientific Advisory Board Dr Holger Heyn, an expert in single-cell genomics and spatial transcriptomics, has joined the Scientific Advisory Board of MiRXES to help advance its development of RNA-powered multi-omics solutions for research and diagnostics. Dr Holger Heyn, MiRXES Scientific Advisory Board member SINGAPORE, 28 July 2021 …
MiRXES Welcomes Genomics Expert to Scientific Advisory Board Read More »
Product Cat No. FGS0019 – Product Information Sheet BlitzAmp Advanced Hotstart 1-Step Probe Master Mix Kit
Press Release MiRXES Secures US$77 Million Series C Funding To Accelerate Multi-Cancer Early Detection Pipeline With Overwhelming Investor Support Led by CR-CP Life Science Fund, this new capital will support MiRXES’s growth as a global leader in cancer early detection tests and preventive healthcare MiRXES team in action SINGAPORE, 8 July 2021 – MiRXES Pte …
Insights Leveling up with MiRXES MiRXES is on the lookout for talents who can contribute to its mission against diseases like cancer through leading-edge diagnostic tools. MiRXES team in action As the saying goes, the early bird catches the worm—and nowhere is this truer than in the world of healthcare. Each year, over a million …
Insights TeamTalk: Jeremiah Decosta As Vice President for Manufacturing and Regulatory Affairs at MiRXES, Jeremiah Decosta harnesses smart technologies to accelerate processes in the plants while ensuring quality diagnostics. Jeremiah Decosta, VP for Manufacturing & Regulatory Affairs at MiRXES. In the world of medical diagnostics manufacturing, there’s no room for error. Even the smallest slip-up …
Insights Meeting the microRNA Profiling Challenge Compared to other commercial microRNA profiling platforms, MiRXES’s ID3EAL qPCR platform stands out when used to discover and validate blood-based miRNA biomarkers. From painful biopsies to invasive procedures, certain diagnostic exams have gotten a bad rap over the years for the discomfort they tend to cause. The 2008 discovery …
Insights TeamTalk: Dr Cheng He For Dr. Cheng He, Vice President for Research and Development at MiRXES, research is all about innovating for impact and improving people’s health in the process. Dr Cheng He, VP for R&D at MiRXES. In MiRXES’ earliest days, the company made its mark with its reverse transcription-quantitative polymerase chain reaction …